Global and United States Iopamidol Injection Market Insights, Forecast to 2027

Publisher Name :
Date: 17-Nov-2021
No. of pages: 131
Inquire Before Buying

Iopamidol Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Iopamidol Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Iopamidol Injection market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- 9 g I/ 30 mL

- 11.1 g I/ 30 mL

- Others

Segment by Application

- Hospitals

- Clinics

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Bracco Imaging

- Sanochemia

- Consentis

- T2Pharma

- Bayer

- Takeda

- Fuji Pharma

- Hikari Pharmaceutical

- BeiLu Pharma

Global and United States Iopamidol Injection Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Iopamidol Injection Product Introduction
1.2 Market by Type
1.2.1 Global Iopamidol Injection Market Size Growth Rate by Type
1.2.2 9 g I/ 30 mL
1.2.3 11.1 g I/ 30 mL
1.2.4 Others
1.3 Market by Application
1.3.1 Global Iopamidol Injection Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Iopamidol Injection Market Size, Estimates and Forecasts
2.1.1 Global Iopamidol Injection Revenue 2016-2027
2.1.2 Global Iopamidol Injection Sales 2016-2027
2.2 Global Iopamidol Injection, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Iopamidol Injection Historical Market Size by Region (2016-2021)
2.3.1 Global Iopamidol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Iopamidol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Iopamidol Injection Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Iopamidol Injection Sales Forecast by Region (2022-2027)
2.4.2 Global Iopamidol Injection Revenue Forecast by Region (2022-2027)
3 Global Iopamidol Injection Competitor Landscape by Players
3.1 Global Top Iopamidol Injection Manufacturers by Sales
3.1.1 Global Iopamidol Injection Sales by Manufacturer (2016-2021)
3.1.2 Global Iopamidol Injection Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Iopamidol Injection Manufacturers by Revenue
3.2.1 Key Iopamidol Injection Manufacturers Covered: Ranking by Revenue
3.2.2 Global Iopamidol Injection Revenue by Manufacturers (2016-2021)
3.2.3 Global Iopamidol Injection Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Iopamidol Injection Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Iopamidol Injection Revenue in 2020
3.2.6 Global Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Iopamidol Injection Price by Manufacturers
3.4 Global Iopamidol Injection Manufacturing Base Distribution, Product Types
3.4.1 Iopamidol Injection Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Iopamidol Injection Product Type
3.4.3 Date of International Manufacturers Enter into Iopamidol Injection Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Iopamidol Injection Market Size by Type (2016-2021)
4.1.1 Global Iopamidol Injection Sales by Type (2016-2021)
4.1.2 Global Iopamidol Injection Revenue by Type (2016-2021)
4.1.3 Iopamidol Injection Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Iopamidol Injection Market Size Forecast by Type (2022-2027)
4.2.1 Global Iopamidol Injection Sales Forecast by Type (2022-2027)
4.2.2 Global Iopamidol Injection Revenue Forecast by Type (2022-2027)
4.2.3 Iopamidol Injection Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Iopamidol Injection Market Size by Application (2016-2021)
5.1.1 Global Iopamidol Injection Sales by Application (2016-2021)
5.1.2 Global Iopamidol Injection Revenue by Application (2016-2021)
5.1.3 Iopamidol Injection Price by Application (2016-2021)
5.2 Iopamidol Injection Market Size Forecast by Application (2022-2027)
5.2.1 Global Iopamidol Injection Sales Forecast by Application (2022-2027)
5.2.2 Global Iopamidol Injection Revenue Forecast by Application (2022-2027)
5.2.3 Global Iopamidol Injection Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Iopamidol Injection Market Size YoY Growth 2016-2027
6.1.1 United States Iopamidol Injection Sales YoY Growth 2016-2027
6.1.2 United States Iopamidol Injection Revenue YoY Growth 2016-2027
6.1.3 United States Iopamidol Injection Market Share in Global Market 2016-2027
6.2 United States Iopamidol Injection Market Size by Players (International and Local Players)
6.2.1 United States Top Iopamidol Injection Players by Sales (2016-2021)
6.2.2 United States Top Iopamidol Injection Players by Revenue (2016-2021)
6.3 United States Iopamidol Injection Historic Market Review by Type (2016-2021)
6.3.1 United States Iopamidol Injection Sales Market Share by Type (2016-2021)
6.3.2 United States Iopamidol Injection Revenue Market Share by Type (2016-2021)
6.3.3 United States Iopamidol Injection Price by Type (2016-2021)
6.4 United States Iopamidol Injection Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Iopamidol Injection Sales Forecast by Type (2022-2027)
6.4.2 United States Iopamidol Injection Revenue Forecast by Type (2022-2027)
6.4.3 United States Iopamidol Injection Price Forecast by Type (2022-2027)
6.5 United States Iopamidol Injection Historic Market Review by Application (2016-2021)
6.5.1 United States Iopamidol Injection Sales Market Share by Application (2016-2021)
6.5.2 United States Iopamidol Injection Revenue Market Share by Application (2016-2021)
6.5.3 United States Iopamidol Injection Price by Application (2016-2021)
6.6 United States Iopamidol Injection Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Iopamidol Injection Sales Forecast by Application (2022-2027)
6.6.2 United States Iopamidol Injection Revenue Forecast by Application (2022-2027)
6.6.3 United States Iopamidol Injection Price Forecast by Application (2022-2027)
7 North America
7.1 North America Iopamidol Injection Market Size YoY Growth 2016-2027
7.2 North America Iopamidol Injection Market Facts & Figures by Country
7.2.1 North America Iopamidol Injection Sales by Country (2016-2021)
7.2.2 North America Iopamidol Injection Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Iopamidol Injection Market Size YoY Growth 2016-2027
8.2 Asia Pacific Iopamidol Injection Market Facts & Figures by Region
8.2.1 Asia Pacific Iopamidol Injection Sales by Region (2016-2021)
8.2.2 Asia Pacific Iopamidol Injection Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Iopamidol Injection Market Size YoY Growth 2016-2027
9.2 Europe Iopamidol Injection Market Facts & Figures by Country
9.2.1 Europe Iopamidol Injection Sales by Country (2016-2021)
9.2.2 Europe Iopamidol Injection Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Iopamidol Injection Market Size YoY Growth 2016-2027
10.2 Latin America Iopamidol Injection Market Facts & Figures by Country
10.2.1 Latin America Iopamidol Injection Sales by Country (2016-2021)
10.2.2 Latin America Iopamidol Injection Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
10.2.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Iopamidol Injection Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Iopamidol Injection Market Facts & Figures by Country
11.2.1 Middle East and Africa Iopamidol Injection Sales by Country (2016-2021)
11.2.2 Middle East and Africa Iopamidol Injection Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Description and Business Overview
12.1.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging Iopamidol Injection Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Sanochemia
12.2.1 Sanochemia Corporation Information
12.2.2 Sanochemia Description and Business Overview
12.2.3 Sanochemia Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanochemia Iopamidol Injection Products Offered
12.2.5 Sanochemia Recent Development
12.3 Consentis
12.3.1 Consentis Corporation Information
12.3.2 Consentis Description and Business Overview
12.3.3 Consentis Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Consentis Iopamidol Injection Products Offered
12.3.5 Consentis Recent Development
12.4 T2Pharma
12.4.1 T2Pharma Corporation Information
12.4.2 T2Pharma Description and Business Overview
12.4.3 T2Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.4.4 T2Pharma Iopamidol Injection Products Offered
12.4.5 T2Pharma Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Description and Business Overview
12.5.3 Bayer Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Iopamidol Injection Products Offered
12.5.5 Bayer Recent Development
12.6 Takeda
12.6.1 Takeda Corporation Information
12.6.2 Takeda Description and Business Overview
12.6.3 Takeda Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Takeda Iopamidol Injection Products Offered
12.6.5 Takeda Recent Development
12.7 Fuji Pharma
12.7.1 Fuji Pharma Corporation Information
12.7.2 Fuji Pharma Description and Business Overview
12.7.3 Fuji Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Fuji Pharma Iopamidol Injection Products Offered
12.7.5 Fuji Pharma Recent Development
12.8 Hikari Pharmaceutical
12.8.1 Hikari Pharmaceutical Corporation Information
12.8.2 Hikari Pharmaceutical Description and Business Overview
12.8.3 Hikari Pharmaceutical Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hikari Pharmaceutical Iopamidol Injection Products Offered
12.8.5 Hikari Pharmaceutical Recent Development
12.9 BeiLu Pharma
12.9.1 BeiLu Pharma Corporation Information
12.9.2 BeiLu Pharma Description and Business Overview
12.9.3 BeiLu Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.9.4 BeiLu Pharma Iopamidol Injection Products Offered
12.9.5 BeiLu Pharma Recent Development
12.11 Bracco Imaging
12.11.1 Bracco Imaging Corporation Information
12.11.2 Bracco Imaging Description and Business Overview
12.11.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bracco Imaging Iopamidol Injection Products Offered
12.11.5 Bracco Imaging Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Iopamidol Injection Industry Trends
13.2 Iopamidol Injection Market Drivers
13.3 Iopamidol Injection Market Challenges
13.4 Iopamidol Injection Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Iopamidol Injection Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Iopamidol Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 9 g I/ 30 mL
Table 3. Major Manufacturers of 11.1 g I/ 30 mL
Table 4. Major Manufacturers of Others
Table 5. Global Iopamidol Injection Market Size Growth Rate by Application (2021-2027) & (K L)
Table 6. Global Iopamidol Injection Market Size by Region (K L) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Iopamidol Injection Sales by Regions (2016-2021) & (K L)
Table 8. Global Iopamidol Injection Sales Market Share by Regions (2016-2021)
Table 9. Global Iopamidol Injection Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Iopamidol Injection Sales Forecast by Region (2022-2027) & (K L)
Table 11. Global Iopamidol Injection Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Iopamidol Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Iopamidol Injection Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Iopamidol Injection Sales by Manufacturers (2016-2021) (K L)
Table 15. Global Iopamidol Injection Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Iopamidol Injection Manufacturers by Revenue (US$ Million) in 2020
Table 17. Iopamidol Injection Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Iopamidol Injection Revenue Share by Manufacturers (2016-2021)
Table 19. Global Iopamidol Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Iopamidol Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iopamidol Injection as of 2020)
Table 21. Key Manufacturers Iopamidol Injection Price (2016-2021) (US$/L)
Table 22. Iopamidol Injection Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Iopamidol Injection Product Type
Table 24. Date of International Manufacturers Enter into Iopamidol Injection Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Iopamidol Injection Sales by Type (2016-2021) (K L)
Table 27. Global Iopamidol Injection Sales Share by Type (2016-2021)
Table 28. Global Iopamidol Injection Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Iopamidol Injection Revenue Share by Type (2016-2021)
Table 30. Iopamidol Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/L)
Table 31. Global Iopamidol Injection Sales Forecast by Type (2022-2027) & (K L)
Table 32. Global Iopamidol Injection Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Iopamidol Injection Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Iopamidol Injection Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Iopamidol Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/L)
Table 36. Global Iopamidol Injection Sales by Application (2016-2021) (K L)
Table 37. Global Iopamidol Injection Sales Share by Application (2016-2021)
Table 38. Global Iopamidol Injection Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Iopamidol Injection Revenue Share by Application (2016-2021)
Table 40. Iopamidol Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/L)
Table 41. Global Iopamidol Injection Sales Forecast by Application (2022-2027) & (K L)
Table 42. Global Iopamidol Injection Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Iopamidol Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Iopamidol Injection Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Iopamidol Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/L)
Table 46. United States Iopamidol Injection Sales (K L) of Key Companies (2016-2021)
Table 47. United States Iopamidol Injection Sales Share by Company (2016-2021)
Table 48. United States Iopamidol Injection Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Iopamidol Injection Revenue Share by Company (2016-2021)
Table 50. United States Iopamidol Injection Sales (K L) by Type (2016-2021)
Table 51. United States Iopamidol Injection Sales Share by Type (2016-2021)
Table 52. United States Iopamidol Injection Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Iopamidol Injection Price (US$/L) by Type (2016-2021)
Table 54. United States Iopamidol Injection Sales (K L) by Type (2022-2027)
Table 55. United States Iopamidol Injection Sales Share by Type (2022-2027)
Table 56. United States Iopamidol Injection Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Iopamidol Injection Revenue Share by Type (2022-2027)
Table 58. United States Iopamidol Injection Price (US$/L) by Type (2022-2027)
Table 59. United States Iopamidol Injection Sales (K L) by Application (2016-2021)
Table 60. United States Iopamidol Injection Sales Share by Application (2016-2021)
Table 61. United States Iopamidol Injection Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Iopamidol Injection Price (US$/L) by Application (2016-2021)
Table 63. United States Iopamidol Injection Sales (K L) by Application (2022-2027)
Table 64. United States Iopamidol Injection Sales Share by Application (2022-2027)
Table 65. United States Iopamidol Injection Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Iopamidol Injection Revenue Share by Application (2022-2027)
Table 67. United States Iopamidol Injection Price (US$/L) by Application (2022-2027)
Table 68. North America Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 69. North America Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 70. North America Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Iopamidol Injection Sales by Region (2016-2021) & (K L)
Table 73. Asia Pacific Iopamidol Injection Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Iopamidol Injection Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Iopamidol Injection Revenue Market Share by Region (2016-2021)
Table 76. Europe Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 77. Europe Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 78. Europe Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 80. Latin America Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 81. Latin America Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 85. Middle East and Africa Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 88. Bracco Imaging Corporation Information
Table 89. Bracco Imaging Description and Business Overview
Table 90. Bracco Imaging Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 91. Bracco Imaging Iopamidol Injection Product
Table 92. Bracco Imaging Recent Development
Table 93. Sanochemia Corporation Information
Table 94. Sanochemia Description and Business Overview
Table 95. Sanochemia Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 96. Sanochemia Product
Table 97. Sanochemia Recent Development
Table 98. Consentis Corporation Information
Table 99. Consentis Description and Business Overview
Table 100. Consentis Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 101. Consentis Product
Table 102. Consentis Recent Development
Table 103. T2Pharma Corporation Information
Table 104. T2Pharma Description and Business Overview
Table 105. T2Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 106. T2Pharma Product
Table 107. T2Pharma Recent Development
Table 108. Bayer Corporation Information
Table 109. Bayer Description and Business Overview
Table 110. Bayer Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 111. Bayer Product
Table 112. Bayer Recent Development
Table 113. Takeda Corporation Information
Table 114. Takeda Description and Business Overview
Table 115. Takeda Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 116. Takeda Product
Table 117. Takeda Recent Development
Table 118. Fuji Pharma Corporation Information
Table 119. Fuji Pharma Description and Business Overview
Table 120. Fuji Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 121. Fuji Pharma Product
Table 122. Fuji Pharma Recent Development
Table 123. Hikari Pharmaceutical Corporation Information
Table 124. Hikari Pharmaceutical Description and Business Overview
Table 125. Hikari Pharmaceutical Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 126. Hikari Pharmaceutical Product
Table 127. Hikari Pharmaceutical Recent Development
Table 128. BeiLu Pharma Corporation Information
Table 129. BeiLu Pharma Description and Business Overview
Table 130. BeiLu Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021)
Table 131. BeiLu Pharma Product
Table 132. BeiLu Pharma Recent Development
Table 133. Iopamidol Injection Market Trends
Table 134. Iopamidol Injection Market Drivers
Table 135. Iopamidol Injection Market Challenges
Table 136. Iopamidol Injection Market Restraints
Table 137. Iopamidol Injection Customers List
Table 138. Iopamidol Injection Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Iopamidol Injection Product Picture
Figure 2. Global Iopamidol Injection Sales Market Share by Type in 2020 & 2027
Figure 3. 9 g I/ 30 mL Product Picture
Figure 4. 11.1 g I/ 30 mL Product Picture
Figure 5. Others Product Picture
Figure 6. Global Iopamidol Injection Sales Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Iopamidol Injection Report Years Considered
Figure 10. Global Iopamidol Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Iopamidol Injection Market Size 2016-2027 (US$ Million)
Figure 12. Global Iopamidol Injection Sales 2016-2027 (K L)
Figure 13. Global Iopamidol Injection Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Iopamidol Injection Sales Market Share by Region (2016-2021)
Figure 15. Global Iopamidol Injection Sales Market Share by Region in 2020
Figure 16. Global Iopamidol Injection Revenue Market Share by Region (2016-2021)
Figure 17. Global Iopamidol Injection Revenue Market Share by Region in 2020
Figure 18. Global Iopamidol Injection Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Iopamidol Injection Revenue in 2020
Figure 20. Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Iopamidol Injection Sales Market Share by Type (2016-2021)
Figure 22. Global Iopamidol Injection Sales Market Share by Type in 2020
Figure 23. Global Iopamidol Injection Revenue Market Share by Type (2016-2021)
Figure 24. Global Iopamidol Injection Revenue Market Share by Type in 2020
Figure 25. Global Iopamidol Injection Sales Market Share by Application (2016-2021)
Figure 26. Global Iopamidol Injection Sales Market Share by Application in 2020
Figure 27. Global Iopamidol Injection Revenue Market Share by Application (2016-2021)
Figure 28. Global Iopamidol Injection Revenue Market Share by Application in 2020
Figure 29. United States Iopamidol Injection Sales Growth Rate 2016-2027 (K L)
Figure 30. United States Iopamidol Injection Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Iopamidol Injection Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Iopamidol Injection Players Market Share by Revenue in Iopamidol Injection in 2020
Figure 33. United States Iopamidol Injection Revenue Share by Type (2016-2021)
Figure 34. United States Iopamidol Injection Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Iopamidol Injection Revenue Share by Application (2016-2021)
Figure 36. United States Iopamidol Injection Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Iopamidol Injection Sales Growth Rate 2016-2021 (K L)
Figure 38. North America Iopamidol Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Iopamidol Injection Sales Market Share by Country in 2020
Figure 40. North America Iopamidol Injection Revenue Market Share by Country in 2020
Figure 41. United States Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 42. United States Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 44. Canada Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Iopamidol Injection Sales Growth Rate 2016-2021 (K L)
Figure 46. Europe Iopamidol Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Iopamidol Injection Sales Market Share by Country in 2020
Figure 48. Europe Iopamidol Injection Revenue Market Share by Country in 2020
Figure 49. Germany Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 50. Germany Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 52. France Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 54. U.K. Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 56. Italy Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 58. Russia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Iopamidol Injection Sales Growth Rate 2016-2021 (K L)
Figure 60. Asia Pacific Iopamidol Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Iopamidol Injection Sales Market Share by Region in 2020
Figure 62. Asia Pacific Iopamidol Injection Revenue Market Share by Region in 2020
Figure 63. China Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 64. China Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 66. Japan Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 68. South Korea Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 70. India Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 72. Australia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 74. China Taiwan Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 76. Indonesia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 78. Thailand Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 80. Malaysia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Iopamidol Injection Sales Growth Rate 2016-2021 (K L)
Figure 82. Latin America Iopamidol Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Iopamidol Injection Sales Market Share by Country in 2020
Figure 84. Latin America Iopamidol Injection Revenue Market Share by Country in 2020
Figure 85. Mexico Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 86. Mexico Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 88. Brazil Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 90. Argentina Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Colombia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 92. Colombia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Iopamidol Injection Sales Growth Rate 2016-2021 (K L)
Figure 94. Middle East and Africa Iopamidol Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Iopamidol Injection Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Iopamidol Injection Revenue Market Share by Country in 2020
Figure 97. Turkey Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 98. Turkey Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 100. Saudi Arabia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Iopamidol Injection Sales Growth Rate (2016-2021) (K L)
Figure 102. UAE Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Iopamidol Injection Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs